LianBio American Depositary Shares
LIAN
LIAN was delisted on the 18th of March, 2024.
40 hedge funds and large institutions have $133M invested in LianBio American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 11 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
9% less funds holding
Funds holding: 44 → 40 (-4)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
21% less capital invested
Capital invested by funds: $168M → $133M (-$34.7M)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$172K |
| 2 |
AAA
Affinity Asset Advisors
New York
|
+$156K |
| 3 |
CIC
Cornercap Investment Counsel
Atlanta,
Georgia
|
+$131K |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$92.9K |
| 5 |
Jane Street
New York
|
+$74.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.42M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.09M |
| 3 |
VA
VR Adviser
New York
|
-$912K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$858K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$410K |
LIAN Hedge Fund Activity: Q4 2022 in Review
40 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q4 2022, worth a combined $133M — down 21% from $168M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of LIAN and 7 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 8 added.
The largest buyer was Millennium Management, adding an estimated $172K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $1.42M sold.
- 40 institutional investors held LianBio American Depositary Shares (LIAN) as of Q4 2022, down from 44 in Q3 2022.
- Funds reported $133M of LianBio American Depositary Shares stock for Q4 2022, down 21% quarter-over-quarter.
- 7 funds opened new LianBio American Depositary Shares positions in Q4 2022 and 11 closed out, a net change of -4 holders.
- The largest LianBio American Depositary Shares buyer in Q4 2022 was Millennium Management, an estimated $172K added.
- The largest LianBio American Depositary Shares seller in Q4 2022 was Hudson Bay Capital Management, an estimated $1.42M sold.
Based on aggregated 13F filings for Q4 2022.